# Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France

> **NCT04325646** · — · COMPLETED · sponsor: **Institut Pasteur** · enrollment: 5000 (actual)

## Conditions studied

- SARS (Severe Acute Respiratory Syndrome)
- COVID-19

## Interventions

- **OTHER:** Human Biological samples
- **OTHER:** Human Biological samples

## Key facts

- **NCT ID:** NCT04325646
- **Lead sponsor:** Institut Pasteur
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-13
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 5000 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04325646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04325646, "Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04325646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*